摘要
目的：观察脉氧监护仪（Masimo Signal Extraction Technology, Masimo SET）在先天性心脏病筛查中的灵敏度及准确性。方法：选择2011年1月-2013年7月生后24 h内入住新生儿病房的256名新生儿为筛查对象，排除存在家族性遗传病、传染病、窒息、脐带异常、胎盘异常、严重贫血者。于生后48~72 h之间通过Masimo SET检测血氧饱和度，并对所有新生儿行心超检查确认。结果：256例新生儿中筛查阳性18例，阴性238例。经心超确认阳性病例中16例、阴性病例中10例为先天性心脏病，经统计学处理差异有显著性（P〈0.05）。Masimo SET检测先天性心脏病的敏感性为88.89%，特异性为95.79%。结论：Masimo SET对新生儿早期筛查先天性心脏病有较大的帮助。
Objective：To evaluate the sensitivity and accuracy of the pulse oxygen monitor （Masimo SET） in the screening of congenital heart disease. Methods：Two hundred and iffty-six babies born in 24 hours during January 2011 to July 2013 in our department were chosen for screening, excluding the presence of familial hereditary diseases, infectious diseases, asphyxia, abnormality of umbilical cord, placenta and severe anemia. Oxygen saturation in blood was assayed with Masimo SET within 48~72 hours after birth and echocardiography was performed to all the babies. Results：There were 18 positive cases and 238 negative cases in 256 neonates based on the screening of Masimo SET and later 16 cases of congenital heart diseases were conifrmed by echocardiography in positive group and 10 cases in negative group. The differences were statistically significant （P〈0.05）. The sensitivity for Masimo SET to screen congenital heart disease was 88.89% with the specificity 95.79%. Conclusion：Masimo SET is of beneift to screening congenital heart disease in early stage of neonates.
出处
《上海医药》
CAS
2014年第19期41-42,73,共3页
Shanghai Medical & Pharmaceutical Journal
